Spandana Sphoorty IPO: Information Analysis

Spandana Sphoorty, the fourth-largest NBFC-MFI in India, has come up with its IPO. Should investors go for it? Here is our analysis.

ICICI Securities' dud IPO tests investing skills of many funds

As of June 30, 45 mutual funds from different AMCs hold over 340 lakh shares in the newly listed stock. Read on

Turn of the mid caps

Mid-sized technology companies have reported higher earnings growth than their larger peers

Magic of media

The changed political environment spells good news for media, with the industry posting double-digit revenue growth in a subdued economy

Going strong

Even though the USFDA created problems for large pharma companies, their smaller counterparts have been doing very well

The sweet pill

Dr Reddy's Laboratories has proved to be one of the best pharma stocks as far as the growth in its revenues and profitability is concerned